48
Views
28
CrossRef citations to date
0
Altmetric
Original Article

The Transition from Viral to Autoimmune Myocarditis

&
Pages 169-176 | Published online: 07 Jul 2009

References

  • Feldman A. M., McNamara D., Myocarditis N. Engl. J. Med. 2000; 343: 1388–1398
  • Aretz H. T., Billingham M. E., Edwards W. D., et al. Myocarditis: a histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1987; 1: 3–14
  • Mason J. W., O'Connell J. B., Herskowitz A., Rose N. R., McManus B. M., Billingham M. E., Moon T. E., The Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N. Engl. J. Med. 1995; 333: 269–275
  • Rose N. R., Baughman K. L. Immune-Mediated Cardiovascular Disease. The Autoimmune Diseases, 3rd ed, N R Rose, I R Mackay, 1998; 623–636
  • Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99: 1091–1100
  • Caforio A. L. P., Goldman J. H., Baig M. K., et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997; 77: 62–67
  • Schultheiss H. P., Bolte H. P. Immunological analysis of auto-antibodies against nucleotide translocator in dilated cardiomyopathy. J. Mol. Cell. Cardiol. 1985; 17: 603
  • Maisch B., Tostel-Soeder R., Stechemesser E., Berg P. A., Koch K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin. Exp. Immunol. 1982; 48: 533
  • Grist N. R., Bell E. J. A six-year study of Coxsackievirus B infections in heart disease. J. Hyg. (London) 1974; 73: 165–172
  • Woodruff J. F. Viral myocarditis. A review. Am. J. Pathol. 1980; 101: 427
  • Wolfgram L. J., Beisel K. W., Herskowitz A., Rose N. R. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J. Immunol. 1986; 136: 1846–1852
  • Pummerer C., Berger P., Fruhwirfh M., Offner C., Neu N. Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis. Lab. Invest. 1991; 65: 538–547
  • Anderson D. R., Wilson J. E., Carthy C. M., Yang D., Kandolf R., McManus B. M. Direct interactions of Coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J. Virol. 1996; 70: 4632–4645
  • Huber S. A., Gauntt C. J., Sakkinen P. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv. Virus Res. 1999; 51: 35–80
  • Huber S. A. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab. Invest. 1997; 76: 691–701
  • Finkel M. S., Oddis C. V., Jacob T. D., Watkins S. C., Hattler B. G., Simmons R. L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–389
  • Oddis C. V., Finkel M. S. Cytokine-stimulated nitrate oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem. Biophys. Res. Comm. 1995; 213: 1002–1009
  • Lowenstein C. J., Hill S. L., Lafond-Walker A., Wu J., Allen G., Landavere M., et al. ). J. Clin. Invest. 1996; 97: 1837–1843
  • Singh V. K., Mehrotra S., Narayan P., Pandey C. M., Agarwal S. S. Modulation of autoimmune diseases by nitric oxide. Immunol. Res. 2000; 22/1: 1–19
  • Hashimoto I., Iatsumi M., Nakagana M. The role of T lymphocytes in the pathogenesis of Coxsackievirus B3 heart disease. Br. J. Exp. Pathol. 1983; 64: 497–504
  • Bachmaier K., Neu N., Pummerer C., Duncan G. S., Mak T. W., Marsuyama T., et al. I-NOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997; 96: 585–591
  • Ishiyama S., Hiroe M., Nishikawa T. M., Abe S., Shimojo T., Ito H., et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997; 95: 489–496
  • Shin T., Kim S., Moon C., Wie M., Kim H. Aminoguanidine-induced amelioration of autoimmune encephalomyelitis is mediated by reduced expression of inducible nitric oxide synthase in the spinal cord. Immunol. Invest. 2000; 29: 233–241
  • Hirono S., Islan O., Nakazawa M., Yoshida Y., Kodama M., Shibata A., et al. Expression of rat inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ. Res. 1997; 80: 11–20
  • Mikami S., Kawashima S., Kanazawa K., Hirata K. I., Karayama Y., Hotta H., et al. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by Coxsackievirus B3. Biochem. Biophys. Res. Comm. 1996; 220: 983–989
  • Kooy N. W., Lewis S. J., Royall J. A., Ye Y. Z., Kelly D. R., Beckman J. S. Extensive tyrosine nitration in human myocardial inflammation: presence of peroxynitrite. Critical Card. Med. 1997; 25: 812–819
  • Okura Y., Yamamoto T., Goto S., Inomata T., Hirono S., Hanawa H., et al. Characterization of cytokine and I-NOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J. Mol. Cell. Cardiol. 1997; 29: 491–502
  • Fields M., Lewis C. G., Lure M. D., Burns W. A., Anthoune W. E. Low dietary iron prevents free radical formation and heart pathology of copper-deficient rats fed fructose. Proc. Soc. Exp. Biol. Med. 1993; 202: 225–232
  • Ferdinandy P., Danial H., Ambrus I., Rothery R. A., Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ. Res. 2000; 87: 241–247
  • Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993; 329: 2002–2012
  • Horwitz M. S., La Cava A., Fine C., Rodriguez E., Ilic A., Sarvetnick N. Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat. Med. 2000; 6: 693–697
  • Muller V., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., et al. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918–1921
  • Smith S. C., Allen P. M. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ. Res. 1992; 70: 856–863
  • Afonosyeva M., Wang Y., Koyza Z., Park S., Zilliox M. I., Schofield B. H., Hill S. L., Rose N. R. Experimental Autoimmune Myocarditis in A/J Mice is an Interleukin-4-Dependent Disease with a Th2 Phenotype. Am. J. Pathology 2001; 159: 193–203
  • Eriksson U., Kurrer M. O., Bingisser R., Eugster H. P., Saremaslani P., Follath R., et al. Lethal autoimmune myocarditis in interferon-7 receptor-deficient mice. Enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation 2001; 103: 18–21
  • Orange J. S., Biron C. A. Characterization of early IL-12 IFN-αβ and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 1996; 156: 4746–4756
  • Okura Y., Takeda K., Honda S., Hanawa H., Watanabe H., Kodama M., et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 help T-cells in rats. Circ. Res. 1998; 82: 1035–1042

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.